{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:48:26Z","timestamp":1790776106464,"version":"4.1.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1212\/con.0000000000000240","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T04:34:17Z","timestamp":1449203657000},"page":"1599-1611","source":"Crossref","is-referenced-by-count":48,"title":["Arbovirus Infections"],"prefix":"10.1212","volume":"21","author":[{"given":"J. David","family":"Beckham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Davis LE Beckham JD Tyler KL. North American encephalitic arboviruses. Neurol Clin 2008; 26 (3): 727\u2013757 ix. doi:10.1016\/j.ncl.2008.03.012.","DOI":"10.1016\/j.ncl.2008.03.012"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Petersen LR Brault AC Nasci RS. West Nile virus: review of the literature. JAMA 2013; 310 (3): 308\u2013315. doi:10.1001\/jama.2013.8042.","DOI":"10.1001\/jama.2013.8042"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Wang P Bai F Zenewicz LA et al. IL-22 signaling contributes to West Nile encephalitis pathogenesis. PLoS One 2012; 7 (8): e44153. doi:10.1371\/journal.pone.0044153.","DOI":"10.1371\/journal.pone.0044153"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","unstructured":"Dai J Wang P Bai F et al. Icam-1 participates in the entry of west nile virus into the central nervous system. J Virol 2008; 82 (8): 4164\u20134168. doi:10.1128\/JVI.02621-07.","DOI":"10.1128\/JVI.02621-07"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","unstructured":"Samuel MA Morrey JD Diamond MS. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J Virol 2007; 81 (6): 2614\u20132623. doi:10.1128\/JVI.02311-06.","DOI":"10.1128\/JVI.02311-06"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","unstructured":"Melian EB Edmonds JH Nagasaki TK et al. West Nile virus NS2A protein facilitates virus-induced apoptosis independently of interferon response. J Gen Virol 2013; 94 (pt 2): 308\u2013313. doi:10.1099\/vir.0.047076-0.","DOI":"10.1099\/vir.0.047076-0"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Yang MR Lee SR Oh W et al. West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus. Cell Microbiol 2008; 10 (1): 165\u2013176. doi:10.1111\/j.1462-5822.2007.01027.x.","DOI":"10.1111\/j.1462-5822.2007.01027.x"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","unstructured":"Medigeshi GR Lancaster AM Hirsch AJ et al. West Nile virus infection activates the unfolded protein response leading to CHOP induction and apoptosis. J Virol 2007; 81 (20): 10849\u201310860. doi:10.1128\/JVI.01151-0.","DOI":"10.1128\/JVI.01151-07"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Kleinschmidt MC Michaelis M Ogbomo H et al. Inhibition of apoptosis prevents West Nile virus induced cell death. BMC Microbiol 2007; 7: 49. doi:10.1186\/1471-2180-7-49.","DOI":"10.1186\/1471-2180-7-49"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Parquet MC Kumatori A Hasebe F et al. West Nile virus-induced bax-dependent apoptosis. FEBS Lett 2001; 500 (1\u20132): 17\u201324. doi:10.1016\/S0014-5793(01)02573-X.","DOI":"10.1016\/S0014-5793(01)02573-X"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Beatman E Oyer R Shives KD et al. West Nile virus growth is independent of autophagy activation. Virology 2012; 433 (1): 262\u2013272. doi:10.1016\/j.virol.2012.08.016.","DOI":"10.1016\/j.virol.2012.08.016"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","unstructured":"Samuel MA Whitby K Keller BC et al. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol 2006; 80 (14): 7009\u20137019. doi:10.1128\/JVI.00489-06.","DOI":"10.1128\/JVI.00489-06"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Sitati EM Diamond MS. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol 2006; 80 (24): 12060\u201312069. doi:10.1128\/JVI.01650-06.","DOI":"10.1128\/JVI.01650-06"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Suthar MS Ma DY Thomas S et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog 2010; 6 (2): e1000757. doi:10.1371\/journal.ppat.1000757.","DOI":"10.1371\/journal.ppat.1000757"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Thompson BS Moesker B Smit JM et al. A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog 2009; 5 (5): e1000453. doi:10.1371\/journal.ppat.1000453.","DOI":"10.1371\/journal.ppat.1000453"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","unstructured":"Zhang B Chan YK Lu B et al. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J Immunol 2008; 180 (4): 2641\u20132649. doi:10.4049\/jimmunol.180.4.2641.","DOI":"10.4049\/jimmunol.180.4.2641"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","unstructured":"Clarke P Leser JS Quick ED et al. Death receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile virus in the absence of a peripheral immune response. J Virol 2014; 88 (2): 1080\u20131089. doi:10.1128\/JVI.02944-13.","DOI":"10.1128\/JVI.02944-13"},{"key":"e_1_3_1_19_2","unstructured":"Centers for Disease Control and Prevention. West Nile virus. www.cdc.gov\/westnile\/index.html. Updated February 12 2015. Accessed October 2 2015."},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","unstructured":"Kramer LD Li J Shi PY. West Nile virus. Lancet Neurol 2007; 6 (2): 171\u2013181. doi:10.1016\/S1474-4422(07)70030-3.","DOI":"10.1016\/S1474-4422(07)70030-3"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","unstructured":"Racsa L Gander R Chung W et al. Clinical features of West Nile virus epidemic in Dallas Texas 2012. Diagn Microbiol Infect Dis 2014; 78 (2): 132\u2013136. doi:10.1016\/j.diagmicrobio.2013.11.006.","DOI":"10.1016\/j.diagmicrobio.2013.11.006"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","unstructured":"Iwamoto M Jernigan DB Guasch A et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348 (22): 2196\u20132203. doi:10.1056\/NEJMoa022987.","DOI":"10.1056\/NEJMoa022987"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"Biggerstaff BJ Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens New York City. Transfusion 2002; 42 (8): 1019\u20131026. doi:10.1046\/j.1537-2995.2002.00167.x.","DOI":"10.1046\/j.1537-2995.2002.00167.x"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Watson JT Pertel PE Jones RC et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med 2004; 141 (5): 360\u2013365. doi:10.7326\/0003-4819-141-5-200409070-00010.","DOI":"10.7326\/0003-4819-141-5-200409070-00010"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","unstructured":"Bode AV Sejvar JJ Pape WJ et al. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 2006; 42 (9): 1234\u20131240. doi:10.1086\/503038.","DOI":"10.1086\/503038"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","unstructured":"Sejvar JJ Haddad MB Tierney BC et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003; 290 (4): 511\u2013515. doi:10.1001\/jama.290.4.511.","DOI":"10.1001\/jama.290.4.511"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","unstructured":"Sejvar JJ Leis AA Stokic DS et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 2003; 9 (7): 788\u2013793. doi:10.3201\/eid0907.030129.","DOI":"10.3201\/eid0907.030129"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","unstructured":"Bains HS Jampol LM Caughron MC Parnell JR. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol 2003; 121 (2): 205\u2013207. doi:10.1001\/archopht.121.2.205.","DOI":"10.1001\/archopht.121.2.205"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","unstructured":"Smith RD Konoplev S DeCourten-Myers G Brown T. West Nile virus encephalitis with myositis and orchitis. Hum Pathol 2004; 35 (2): 254\u2013258. doi:10.1016\/j.humpath.2003.09.007.","DOI":"10.1016\/j.humpath.2003.09.007"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","unstructured":"Jean CM Honarmand S Louie JK Glaser CA. Risk factors for West Nile virus neuroinvasive disease California 2005. Emerg Infect Dis 2007; 13 (12): 1918\u20131920. doi:10.3201\/eid1312.061265.","DOI":"10.3201\/eid1312.061265"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","unstructured":"Nash D Mostashari F Fine A et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344 (24): 1807\u20131814. doi:10.1056\/NEJM200106143442401.","DOI":"10.1056\/NEJM200106143442401"},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","unstructured":"Yakub I Lillibridge KM Moran A et al. Single nucleotide polymorphisms in genes for 2\u2032-5\u2032-oligoadenylate synthetase and RNase L in patients hospitalized with West Nile virus infection. J Infect Dis 2005; 192 (10): 1741\u20131748. doi:10.1086\/497340.","DOI":"10.1086\/497340"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","unstructured":"Lim JK Louie CY Glaser C et al. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J Infect Dis 2008; 197 (2): 262\u2013265. doi:10.1086\/524691.","DOI":"10.1086\/524691"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","unstructured":"Tyler KL Pape J Goody RJ et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology 2006; 66 (3): 361\u2013365. doi:10.1212\/01.wnl.0000195890.70898.1f.","DOI":"10.1212\/01.wnl.0000195890.70898.1f"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","unstructured":"Beckham JD Tyler KL. Neuro-intensive care of patients with acute CNS infections. Neurotherapeutics 2012; 9 (1): 124\u2013138. doi:10.1007\/s13311-011-0086-5.","DOI":"10.1007\/s13311-011-0086-5"},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","unstructured":"Debiasi RL Tyler KL. West Nile virus meningoencephalitis. Nat Clin Pract Neurol 2006; 2 (5): 264\u2013275. doi:10.1038\/ncpneuro0176.","DOI":"10.1038\/ncpneuro0176"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","unstructured":"Davis LE DeBiasi R Goade DE et al. West Nile virus neuroinvasive disease. Ann Neurol 2006; 60 (3): 286\u2013300. doi:10.1002\/ana.20959.","DOI":"10.1002\/ana.20959"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","unstructured":"Sejvar JJ Marfin AA. Manifestations of West Nile neuroinvasive disease. Rev Med Virol 2006; 16 (4): 209\u2013224. doi:10.1002\/rmv.501.","DOI":"10.1002\/rmv.501"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","unstructured":"Sejvar JJ. West Nile virus and \u201cpoliomyelitis\u201d. Neurology 2004; 63 (2): 206\u2013207. doi:10.1212\/01.WNL.0000130361.62281.69.","DOI":"10.1212\/01.WNL.0000130361.62281.69"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","unstructured":"Shi PY Wong SJ. Serologic diagnosis of West Nile virus infection. Expert Rev Mol Diagn 2003; 3 (6): 733\u2013741. doi:10.1586\/14737159.3.6.733.","DOI":"10.1586\/14737159.3.6.733"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","unstructured":"Hart J Jr Tillman G Kraut MA et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis 2014; 14: 248. doi:10.1186\/1471-2334-14-248.","DOI":"10.1186\/1471-2334-14-248"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","unstructured":"Pyrgos V Younus F. High-dose steroids in the management of acute flaccid paralysis due to West Nile virus infection. Scand J Infect Dis 2004; 36 (6\u20137): 509\u2013512. doi:10.1080\/00365540410020659.","DOI":"10.1080\/00365540410020659"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","unstructured":"Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 2007; 44 (12): 1617\u20131624. doi:10.1086\/518281.","DOI":"10.1086\/518281"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","unstructured":"Sahu R Verma R Jain A et al. Neurologic complications in dengue virus infection: a prospective cohort study. Neurology 2014; 83 (18): 1601\u20131609. doi:10.1212\/WNL.0000000000000935.","DOI":"10.1212\/WNL.0000000000000935"},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","unstructured":"Sung S Wurcel AG Whittier S et al. Powassan meningoencephalitis New York New York USA. Emerg Infect Dis 2013; 19: (9). doi:10.3201\/eid1909.121846.","DOI":"10.3201\/eid1909.121846"},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","unstructured":"Tavakoli NP Wang H Dupuis M et al. Fatal case of deer tick virus encephalitis. N Engl J Med 2009; 360 (20): 2099\u20132107. doi:10.1056\/NEJMoa0806326.","DOI":"10.1056\/NEJMoa0806326"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","unstructured":"Unnasch RS Sprenger T Katholi CR et al. A dynamic transmission model of eastern equine encephalitis virus. Ecol Modell 2006; 192 (3\u20134): 425\u2013440. doi:10.1016\/j.ecolmodel.2005.07.011.","DOI":"10.1016\/j.ecolmodel.2005.07.011"},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","unstructured":"Mitchell CJ Niebylski ML Smith GC et al. Isolation of eastern equine encephalitis virus from Aedes albopictus in Florida. Science 1992; 257 (5069): 526\u2013527. doi:10.1126\/science.1321985.","DOI":"10.1126\/science.1321985"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","unstructured":"Weaver SC Salas R Rico-Hesse R et al. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet 1996; 348 (9025): 436\u2013440. doi:10.1016\/S0140-6736(96)02275-1.","DOI":"10.1016\/S0140-6736(96)02275-1"},{"key":"e_1_3_1_61_2","doi-asserted-by":"crossref","unstructured":"Pialoux G Gauzere BA Jaureguiberry S Strobel M. Chikungunya an epidemic arbovirosis. Lancet Infect Dis 2007; 7 (5): 319\u2013327. doi:10.1016\/S1473-3099(07)70107-X.","DOI":"10.1016\/S1473-3099(07)70107-X"},{"key":"e_1_3_1_62_2","doi-asserted-by":"crossref","unstructured":"Prince HE Seaton BL Matud JL Batterman HJ. Chikungunya virus RNA and antibody testing at a national reference laboratory since the emergence of Chikungunya in the Americas. Clin Vaccine Immunol 2015; 22 (3): 291\u2013297. doi:10.1128\/CVI.00720-14.","DOI":"10.1128\/CVI.00720-14"},{"key":"e_1_3_1_63_2","doi-asserted-by":"crossref","unstructured":"Lindsey NP Prince HE Kosoy O et al. Chikungunya virus infections among travelers\u2014United States 2010-2013. Am J Trop Med Hyg 2015; 92 (1): 82\u201387. doi:10.4269\/ajtmh.14-0442.","DOI":"10.4269\/ajtmh.14-0442"},{"key":"e_1_3_1_64_2","doi-asserted-by":"crossref","unstructured":"Tsetsarkin KA Weaver SC. Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Pathog 2011; 7 (12): e1002412. doi:10.1371\/journal.ppat.1002412.","DOI":"10.1371\/journal.ppat.1002412"},{"key":"e_1_3_1_65_2","doi-asserted-by":"crossref","unstructured":"Nelson J Waggoner JJ Sahoo MK et al. Encephalitis caused by Chikungunya virus in a traveler from the Kingdom of Tonga. J Clin Microbiol 2014; 52 (9): 3459\u20133461. doi:10.1128\/JCM.01288-14.","DOI":"10.1128\/JCM.01288-14"},{"key":"e_1_3_1_66_2","doi-asserted-by":"crossref","unstructured":"Chusri S Siripaitoon P Hirunpat S Silpapojakul K. Case reports of neuro-Chikungunya in southern Thailand. Am J Trop Med Hyg 2011; 85 (2): 386\u2013389. doi:10.4269\/ajtmh.2011.10-0725.","DOI":"10.4269\/ajtmh.2011.10-0725"},{"key":"e_1_3_1_67_2","doi-asserted-by":"crossref","unstructured":"Ganesan K Diwan A Shankar SK et al. Chikungunya encephalomyeloradiculitis: report of 2 cases with neuroimaging and 1 case with autopsy findings. AJNR Am J Neuroradiol 2008; 29 (9): 1636\u20131637. doi:10.3174\/ajnr.A1133.","DOI":"10.3174\/ajnr.A1133"},{"key":"e_1_3_1_68_2","doi-asserted-by":"crossref","unstructured":"Robin S Ramful D Le Seach\u2019 F et al. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol 2008; 23 (9): 1028\u20131035. doi:10.1177\/0883073808314151.","DOI":"10.1177\/0883073808314151"},{"key":"e_1_3_1_70_2","doi-asserted-by":"crossref","unstructured":"Rust RS Thompson WH Matthews CG et al. La Crosse and other forms of California encephalitis. J Child Neurol 1999; 14 (1): 1\u201314. doi:10.1177\/088307389901400101.","DOI":"10.1177\/088307389901400101"},{"key":"e_1_3_1_71_2","doi-asserted-by":"crossref","unstructured":"Haddow AD Bixler D Odoi A. The spatial epidemiology and clinical features of reported cases of La Crosse virus infection in West Virginia from 2003 to 2007. BMC Infect Dis 2011; 11: 29. doi:10.1186\/1471-2334-11-29.","DOI":"10.1186\/1471-2334-11-29"},{"key":"e_1_3_1_72_2","doi-asserted-by":"crossref","unstructured":"McJunkin JE de los Reyes EC Irazuzta JE et al. La Crosse encephalitis in children. N Engl J Med 2001; 344 (11): 801\u2013807. doi:10.1056\/NEJM200103153441103.","DOI":"10.1056\/NEJM200103153441103"},{"key":"e_1_3_1_75_2","doi-asserted-by":"crossref","unstructured":"McJunkin JE Nahata MC De Los Reyes EC et al. Safety and pharmacokinetics of ribavirin for the treatment of la crosse encephalitis. Pediatr Infect Dis J 2011; 30 (10): 860\u2013865. doi:10.1097\/INF.0b013e31821c922c.","DOI":"10.1097\/INF.0b013e31821c922c"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/CON.0000000000000240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:09:31Z","timestamp":1752156571000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1212\/CON.0000000000000240"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000240","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}